These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27332919)

  • 21. Metformin for Improving Maternal and Infant Outcomes in Pregnant Women Who are Obese.
    Jainchill AL; Gawrys BL; Arnold JJ
    Am Fam Physician; 2019 Mar; 99(5):Online. PubMed ID: 30811164
    [No Abstract]   [Full Text] [Related]  

  • 22. Placental dysfunction in obese women and antenatal surveillance strategies.
    Jeve YB; Konje JC; Doshani A
    Best Pract Res Clin Obstet Gynaecol; 2015 Apr; 29(3):350-64. PubMed ID: 25457859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiology, detection, and management of fetal macrosomia in pregnancies complicated by diabetes mellitus.
    Sacks DA
    Clin Obstet Gynecol; 2007 Dec; 50(4):980-9. PubMed ID: 17982341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
    Yang YD; Zhai GR; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovarian syndrome.
    Kumar HK
    Saudi Med J; 2008 Apr; 29(4):625. PubMed ID: 18382816
    [No Abstract]   [Full Text] [Related]  

  • 26. The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus.
    Tertti K; Laine K; Ekblad U; Rinne V; Rönnemaa T
    Acta Diabetol; 2014 Oct; 51(5):731-8. PubMed ID: 24633859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
    Goldenberg N; Glueck C
    Minerva Ginecol; 2008 Feb; 60(1):63-75. PubMed ID: 18277353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
    Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
    Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gestational diabetes--whom do we treat?
    Sacks DA
    N Engl J Med; 2009 Oct; 361(14):1396-8. PubMed ID: 19797287
    [No Abstract]   [Full Text] [Related]  

  • 30. Diabetes control without weight gain.
    Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis.
    Feng L; Lin XF; Wan ZH; Hu D; Du YK
    Gynecol Endocrinol; 2015; 31(11):833-9. PubMed ID: 26440203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus.
    Yki-Järvinen H; Nikkilä K; Mäkimattila S
    Drugs; 1999; 58 Suppl 1():53-4; discussion 75-82. PubMed ID: 10576526
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case report.
    Guido M; Romualdi D; Belosi C; Selvaggi L; Lanzone A
    J Endocrinol Invest; 2004 Jan; 27(1):70-5. PubMed ID: 15053248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
    Out M; Miedema I; Jager-Wittenaar H; van der Schans C; Krijnen W; Lehert P; Stehouwer C; Kooy A
    Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.
    Casteels K; Fieuws S; van Helvoirt M; Verpoorten C; Goemans N; Coudyzer W; Loeckx D; de Zegher F
    Pediatr Diabetes; 2010 Feb; 11(1):61-9. PubMed ID: 19496972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo.
    Vanky E; Nordskar JJ; Leithe H; Hjorth-Hansen AK; Martinussen M; Carlsen SM
    BJOG; 2012 Oct; 119(11):1403-9. PubMed ID: 22827167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of gestational weight gain outside the Institute of Medicine Guidelines.
    Asvanarunat E
    J Med Assoc Thai; 2014 Nov; 97(11):1119-25. PubMed ID: 25675675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.